Dengue fever is a mosquito-borne viral infection that causes high fever, severe body aches, and in a small percentage of cases, life-threatening complications. In 2024, the World Health Organization recorded over 14.4 million cases across all six global regions, making it one of the most widespread mosquito-transmitted diseases on the planet.
How Dengue Spreads
Dengue is caused by four distinct virus serotypes, labeled DENV-1 through DENV-4. All four spread through the bite of infected Aedes mosquitoes, primarily Aedes aegypti. A second species, Aedes albopictus (the Asian tiger mosquito), also transmits the virus but plays a smaller role globally. These mosquitoes are daytime biters that thrive in urban and suburban environments, breeding in small pools of standing water like flower pots, tires, and rain gutters.
You can be infected by any of the four serotypes, and recovering from one gives you long-term immunity to that specific serotype only. That means a person can get dengue up to four times in a lifetime, and as explained below, a second infection with a different serotype actually carries more risk than the first.
Symptoms and the Three Phases of Illness
Dengue typically moves through three phases: febrile, critical, and recovery.
The febrile phase begins suddenly, usually 4 to 10 days after a mosquito bite. Symptoms include a high fever (often 104°F / 40°C), intense headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, and sometimes a flat red rash. This phase lasts roughly 2 to 7 days. The joint and muscle pain can be so intense that dengue has long been called “breakbone fever.”
The critical phase, when it occurs, begins right around the time the fever breaks. This is counterintuitive: many people assume they’re getting better just as the most dangerous window opens. During this 24- to 48-hour period, the small blood vessels become leaky and plasma (the fluid portion of blood) seeps out of the bloodstream. Warning signs include severe abdominal pain, persistent vomiting, visible fluid accumulation (such as a swollen belly), mucosal bleeding from the gums or nose, extreme fatigue, and restlessness. Not everyone enters this critical phase, but recognizing these warning signs early is what prevents most dengue deaths.
The recovery phase follows within 2 to 3 days as the vascular leaking stops and fluid is reabsorbed. Energy returns gradually, and a second rash sometimes appears. Full recovery typically takes one to two weeks, though fatigue can linger longer.
Why Blood Vessels Leak
The hallmark of severe dengue is plasma leakage, and the mechanism involves the body’s own immune response turning destructive. When the virus infects cells, those cells release a flood of inflammatory signaling molecules. This cascade damages the glycocalyx, a thin protective layer lining the inside of blood vessels. Normally the glycocalyx acts as a barrier, keeping large molecules and fluids inside the vessel. Once it breaks down, plasma escapes into surrounding tissue.
A viral protein called NS1 accelerates this process by binding directly to structural components of the glycocalyx, further weakening the vessel wall. The result is a rapid drop in blood volume that can lead to shock if fluids aren’t replaced quickly enough.
Why a Second Infection Is More Dangerous
One of dengue’s most unusual features is that a second infection with a different serotype carries a higher risk of severe disease than the first. The reason is a process called antibody-dependent enhancement.
After your first dengue infection, your immune system produces antibodies tailored to that specific serotype. When a different serotype enters the body months or years later, those existing antibodies recognize the new virus but can’t neutralize it effectively. Instead, they latch onto the virus and essentially escort it into immune cells, using the cells’ own receptor doors. Once inside, the virus hijacks the cell’s machinery, replicates more efficiently, and triggers a much larger inflammatory response. The result is higher levels of virus in the blood and more aggressive vascular leakage.
Despite this increased risk, fewer than 5% of secondary infections progress to severe dengue. Certain patterns in the antibody structure appear to influence who tips into severe disease and who doesn’t, but the full picture remains incomplete.
How Dengue Is Diagnosed
Diagnosis depends on timing. During the first seven days of symptoms, a test that detects a specific viral protein (NS1 antigen) is recommended and performs about as well as molecular (PCR) testing. This can be done with a rapid bedside test or a lab-based version. An antibody test (IgM) can be run alongside it to improve accuracy, since antibodies start appearing as the antigen level drops.
If both the NS1 and IgM tests come back negative but dengue is still suspected, a second blood draw during the recovery period can confirm or rule out infection. In practice, diagnosis in endemic regions often relies on clinical symptoms combined with a basic blood count showing a dropping platelet count and rising blood concentration.
Treatment and Pain Management
There is no antiviral drug for dengue. Treatment is supportive: managing fever, preventing dehydration, and monitoring for warning signs of severe disease. For most people, this means rest, plenty of fluids, and acetaminophen (paracetamol) for pain and fever.
Ibuprofen, aspirin, and other nonsteroidal anti-inflammatory drugs are contraindicated. The reason is straightforward: dengue lowers platelet counts, which impairs blood clotting, and NSAIDs further increase bleeding risk. Even a modest nosebleed or gum bleed can become harder to control when both the disease and the pain medication are working against clotting. Stick with acetaminophen.
For the roughly 5% of cases that progress to severe dengue, hospital-based fluid replacement is the cornerstone of treatment. When caught early, the critical phase is manageable and mortality drops below 1%. Without timely care, the fatality rate climbs significantly.
Vaccination
A vaccine called TAK-003 (sold as Qdenga) is currently recommended by the WHO for children aged 6 to 16 in areas with high dengue transmission. It covers all four serotypes, though its effectiveness varies by serotype. The WHO has not recommended it for children under 6 due to lower efficacy in that age group, or for areas with low to moderate transmission, where the balance of benefit and risk is less clear.
Adults with underlying health conditions living in endemic countries may be offered the vaccine outside the standard age range, with an upper limit of 60 years. For travelers who have never had dengue, the benefit is lower than for people who’ve already been exposed to the virus. A previous vaccine, Dengvaxia, requires proof of a prior dengue infection before administration, because it can increase the risk of severe disease in people who’ve never been infected.
Protecting Yourself From Mosquito Bites
Prevention still centers on avoiding bites, especially during early morning and late afternoon hours when Aedes mosquitoes are most active. Insect repellents containing DEET, picaridin, or oil of lemon eucalyptus are effective. Long sleeves and pants help, particularly in shaded outdoor areas where these mosquitoes rest. Air conditioning and window screens reduce indoor exposure substantially.
Eliminating standing water around your home removes breeding habitat. Aedes aegypti needs only a bottle cap’s worth of water to lay eggs, so even small containers like plant saucers, pet dishes, and clogged drains matter. In endemic areas, these basic environmental measures remain the most reliable way to reduce transmission at the community level.